Trials / Completed
CompletedNCT04096001
Woebot for Substance Use Disorders
RCT of Woebot for Substance Use Disorders Phase 1
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Woebot Health · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Phase 1 of this study aims to develop a digitally-delivered substance use disorder program through the Woebot app-based platform (W-SUDs) and evaluate the effectiveness of, patient satisfaction with and the acceptability of W-SUDs as a substance use management tool.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Woebot-SUDs (W-SUDs) | Woebot-SUDs (W-SUDS), an artificially intelligence-powered conversational agent on a smartphone app, eliminates most current SUDs treatment barriers while simultaneously leveraging technology to enhance user experience and engagement. W-SUDs expands and refines existing SUDs treatments by adapting skills from cognitive behavioral therapy, motivational interviewing, and dialectical behavior therapy. |
Timeline
- Start date
- 2020-03-26
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
- First posted
- 2019-09-19
- Last updated
- 2022-08-31
- Results posted
- 2022-08-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04096001. Inclusion in this directory is not an endorsement.